Table Of Content

Contraception Contraception 67 (2003) 493-495 Author Index Volume 67 January-June, 2003 Abetz, L., 187 Cerrota, G., 277 El-Tagy, A., 229 Abrams, L. S., 93 Cetinkaya, F., 133 Endrikat, J., 423 Achiron, R., 473 Chaki, S. P., 73 Evans, M., 259 Acunzo, G., 355 Chami, S., 457 Ahued, J. R., 367 Chan, C. P. B., 101 Faccin, C. S., 19 Albrecht, G., 367 Chen, J., 281 Farley, T., 6 Aleem, M., 409 Cheng, L., 1, 281 Ferden, S., 259 Alvarado, G., 367 Chies, J. A. B., 247 Fernandez, M., 367 Amro, B. I., 485 Choudhuri, J., 409 Fiddes, P., 313 Andersen Clark, K., 287 Christow, A., 319 Fisher, A., 431 Andolsek-Jeras, L., 33 Chuanrong, Z., 379 Fletcher, J., 313 Araya, R., 161 Cifuentes, R., 367 Flores, J. G., 367 Arreola, R. G., 367 Clark, V. A., 139 Frezieres, R. G., 139 Ashton, J., 53 COCON Group, 39 Friedman, A., 431 Avecilla-Palau, A., 235 Coulter, D., 53 Fuchs, F. D., 19 Avonts, D., 491 Creasy, G. W., 93 Furedi, A., 343 Critchley, H. O. D., 467 Baird, D. T., 1 Croxatto, H. B., 335, 415 Gainer, E., 195 Bajos, N., 39 Gallo, M. F., 15 Bal, W., 477 Dada, K., | Gamzu, R., 267, 473 Balasinor, N., 409 Dalve-Endres, A. M., 449 Gaspard, U., 423 Baldaszti, E., 87 Darney, P., 201 Gemzell-Danielsson, K., 319 Barambio, S., 457 Das, H. C., 73 Gerhardt, A., 287 Bartholomew, N. E., 115 de Carvalho Formiga, M. C., 385 Gerlinger, C., 423 Bassol, S., 367 de Cassia da Silveira e Sa, R., 327 Gerofi, J., 65 Bastidas, J. M., 161 de la Loge, C., 187 Gill-Sharma, M. K., 409 Beckman, L. J., 207 de Moura Reporedo, M., 327 Glasier, A. F., 1, 281, 313 Benson, J., 287 de Oliveira, H. C., 367 Glyn Allen, J., 93 Bernstein, L., 139 de Padua, K. S., 391 Goldberg, A., 201 Berquéo, E., 385 de Pierro, A. N., 367 Gomez, J., 367 Bianchia, P. G., 107 De Simone, R., 277 Gomez-Mora, H., 161 Bianchi-Demicheli, F de Vargas, F., 457 Goulard, H., 39 Bifulco, G., 277, 35 Dean, G., 201 Grimes, D. A., 15 Bigrigg, A., 259 Denekens, J., 491 Guerrero-Carreno, F. J., 273 Bid, S.. T., 207 Dhar, J. D., 403 Guida, M., 355 Blanchard, K., 343 Di Carlo, C. 355 Gupta, G., 403 Blumenthal, P. D., 207 Di Spiezio Sardo, A., Gurucharri, C., 367 Botti, G., 367 Dijak, V., 219 Botto, E., 367 Doncel, G. F., 241 Hammarstrém, M., 299 Breitkopf, D. M., 349 Dorflinger, L., 167 Hammond, G. L., 93 Brening, R. K., 449 D’ Souza, S., 409 Hardy, E., 391 Buicu, C., 423 Dudley, S., 287 Haring, T., 271 Bungay, H., 343 Dumont, P., 107 Harrison-Woolrych, M., 53 Dwivedi, A. K., 403 Harvey, S. M., 207 Dykes, A-K., 439 Campana, A., 107 Haukkamaa, M., 223 Carbonell, J. L..L., 457 Hausknecht, R., 463 Cardenas, L., 201 Edelman, A., 9, 49 Hays, M., 397 Gasas;.P.. Ro F:, 367 Elgan, C., 439 Hebling, E. M., 391 Celis-Gonzalez, C., 367 Ellertson, C., 167, 259 Heikinheimo, O., 223 0010-7824/03/$ — see front matter © 2003 Elsevier Inc. All rights reserved. 494 A J , , Author Index Contra eption 6 193-495 Heithecker, R., 423 Mistik, S., 133 Rosen, M. P., 349 Heredia, M. G., 367 Mittal, S., 295 Rountree, W., 373 Ho, P. C., 1, 10] Modzelewska, B., 477 Rowlands, S., 42] Hopkins, K., 385 Moore, = 25: 361 Hulthén Varli, I., 299 Moos, M.-K., 115 Sanchez, C., 457 Moreno, V., 235 Sakr, E., 229 Illingworth, P. J., 467 Issa, A. H., 229 Morrow, E., 41 Salazar, G., 367 Morrow, S., 281 Salhab, A. S., 485 Mulders, T. M. T., 271 Salhan, S., 213 Jensen, J., 9, 49 Salvador, I., 457 Job-Spira, N., 39 Nagar, M., 133 Juneja, H. S., 409 Nagamani, M., 349 Samsioe, G., 439 ! Sanders, L., 343 Nandedkar, T., 151 Sarda, N., 213 Kafrissen, M., 43] Nafiez, M., 367 Savaris, R., 247 Katz, D. F., 57 Nappi, C., 277, 355 Saxena, P., 213 Keller, P. J., 79 Narciso Leite, M., 327 Scheen, A., 423 Kettle, H., 492 Natarajan, J., 93 Schiff, G., 473 Kholkute, S., 151] Nazerali, H., 397 Schramm, G., 305 Kleszczewski, T., 477 Neff, M., 79 Schulz, K. F., 15 Kocijancic, A., 33 Nelson, A. L., 139 Scott, A., 313 Kostrzewska, A., 477 Nelson, E., 49 Setty, B. S., 403 Kuhl, H., 25, 361 Nichols, M. D., 9, 49, 207 Shangold, G., 431 Kumar, S., 295 Nobrega de Almeida, R., 327 Sheffer-Mimouni, G., 267 Kutschera, E., 25, 361 Novak, A., 187 Shelton, J. D., 421 Kuyoh, M. A., 15 Shields, W. C., 251, 341 Kwiecien, M., 9 Ortiz, O. C., 367 Shiyuan, L., 379 Osis, M. J. D., 391 Shomaf, M. S., 485 LaGuardia, K. D., 431 Otero-Flores, J. B., 273 Shulman, A., 473 Lastreto, E., 367 Owen, D. H., 57 Siiteri, P. K., 93 Lavine, M. L., 57 Silva, J., 367 Leadbetter, C., 259 Pandey, K. R., 397 Sipowicz, M., 477 Leal, O. F., 385 Parte, P., 409 Smith, K. B., 1, 281 lee: 5-H... 25, 361 Pathak, L. R., 397 Sokal, D. C., 229, 241, 397 Lefebvre, P., 423 Patrick, K., 449 Sollet, C., 195 Lessing, J. B., 267 Pauzner, D., 267 Lévy, D., 195 Souza, M. R., 385 Pefia, E. P., 367 Li, C. F. I., 101 Stanford, J. B., 253, 333 Peacock, K., 139 Steffens, D., 305 la. X.,.379 Penagos, G., 367 Stewart, F. H., 251, 341 Lidor, A., 473 Percossi, G., 367 Suhonen, S., 223 Lindelius, A., 299 Peremans, L., 49] Sun, X., 319 Llados, C. M., 415 Perheentupa, A., 467 Lohr, K. N., 115 Perpétuo, I. H. O., 385 Tanda, R., 457 Lopez, C. R., 367 Perrin, E., 107 Thapa, S., 397 LLLiouiébdsiicachnkkceea,, , FK.J.,., N18.07,7 19 PPPieintcteaerrrsd,,o , BJ.. ,L .J.,3, 34 517 TThhee ONroarlg eCsotnitmraatcee ptSitvued y aGndr oup, 431] | Hemostasis Study Group, 173 Podhradsky, L., 219 Tikka, M., 223 MMMiaaiijlkrlheaurm,rk ia,Ar ., J.L .D,P. . ,4 D14.5,0 3 409 PPootptee,r , M.B.,, 6655 TToormomiatsieclhl-iR,u toG,. CA..,, 1355 5 | Potter, J. E., 385 Torres, L. A., 367 Mari, J., 457~ ] Prezely. 3.33 Mare, J., 33 Prieto, G., 367 TTrouzszsienlil,, RJ.., I1.,6 73,6 72 59 Marions, L., 319 Maslovitch, S., 267 Randall, L., 287 i MMcaNzieciilolgyl,u , A. M.S,. , 143637 Rauchfuss, M., 253 UUllmmaannnn,, AM..,, 119955 | Reddy, P. R., 241 Mellinger, U., 25, 361 Reyes-Marquez, R., 367 A Valero, F., 457 Mercorio, F., 277 Ricalde, R. L., 367 MMiekroklia-Fjeelzdy,k , G.R . S.T,. , 792 53, 333 RRiovderriag,u ezR.,, J3.7, 3 457 vvaann ddeerr SMpeuuyl,e n,Z . EM.. ,A .,| 187 Van Royen, P., 49] Misro, M. M., 73 Rogers, K., 207 Vanacore, F., 277 Author Index / Contrac eption 67 | Vazquez-Estrada, L. A., 273 Webb, A., 259 Xiaoping, P., 379 Velazco, A., 457 Wellings, K., | Xiaogin, C., 379 Vera, R., 161 Westhoff, C., 41 Verhoeven, V., 491 Wiebe, E., 219 Vimala, N., 295 Wiegratz, I., 25, 361 Yazlle, M. E. D. H.. 367 von Hertzen, H., 259 Wimmer-Puchinger, B., 87 Young, S. L., 349 Winkler, U. H., 25, 361 Nong, C. Y. G., 101 Wadia, P., 15] Wood, B. L., 241 Zalel, Y., 473 Walsh, T. L., 139 Wraxall, B. G. D., 139 Zaneveld, L. J. D., 391 Contraception i ELSEVIER Contraception 67 (2003) 497-500 Subject Index Volume 67 January—June, 2003 Abortion experience of women, medical or surgical, 41 effect of amenorrhea, | Acceptability, Contraceptive effect, meloxicam (rabbit), 485 combined oral hormonal contraceptives, 281 Contraceptive gel viscosity, effect of temperature and pH, levonorgestrel-releasing IUS, 87 57 manual vs electric aspiration for abortion, 201, 207 Contraceptive practices, before and after termination of NuvaRing®, 187 pregnancy, 107 Acceptability of contraception, effect of amenorrhea, | Contraceptive vaginal ring, Access and counseling, emergency contraception, 39 ethinyl estrradiol + etonogestrel, 187 Accessory sex gland function, effect of RISUG, 73 NuvaRing®, 187, 271 Adrenal parameters, effect of OCs, 361 Copper, Advance provision service, emergency contraception, 343 effect on expression of 83 integrin subunit, 247 Advantage-S, rheological properties, 57 effect on uterine activity, 477 Amenorrhea, effect of contraception, | Copper IUDs, uterine factors and risk of pregnancy, 235 Anti-androgenic properties, ethinylestradiol + Copper-bearing IUD, replacement of inert IUDs, 379 chlormadinone acetate, 305 Copper-T 380A, post-abortal insertion, 229 Antifertility effect, FSH binding inhibitor (marmoset), 151 Copper-vasopressin complex, effect on myometrium, 477 Association of Reproductive Health Professionls (ARHP) Counseling, prevention of unintended pregnancy, 115 editorial, Cupric ions, effect on spermatozoa motility, 161 over-the-counter status for emergency contraception, Current trends, emergency contraception pills, 449 342 Depot medroxyprogesterone acetate, effect on bone mass, Preserving Core Values in Science Statement, 79 Diaphragm vs sponge for contraception, 15 Diltiazem, effect on sperm, 241 B3 integrin subunit expression, effect of copper, 2 Discontinuation of Norplant use, effect of menstrual Bleeding patterns, effect of ethinyl estradiol + problems, 373 levonorgestrel, 9 Blood pressure, effect of OCs, 19 Blood pressure parameters, effect of OCs, 361 Early abortion services, provider survey, 287 Bone mass, effect of DMPA use, 79 Ectopic pregnancy risk, levonorgestrel emergency Bone metabolism, contraception, 267 effect of estradiol + levonorgestrel, 33 Effectiveness, influence of vitamin D receptor genotype, 33 emergency contraceptive pills, 259 Bone mineral density, ethinyl estradiol + chlormadinone acetate, 305 effect of ethinyl estradiol + gestodene, 355 vasectomy, 397 effect of smoking and OC use, 439 Efficacy, safety and cycle control, use of ethiny] estradiol + norgestimate, 431 Cannula fracture, complication in surgical abortions, 49 Electric vs manual aspiration, surgical abortion, 201, 307 Carbohydrate metabolism, effect of OCs, 423 Emergency contraception, Chaperones during pelvic examination, questionnaire access and counseling, 39 survey, 313 advance provision service, 343 Chlamydia infection screening, 491, 492 analysis of website use, 195 Clinical experience, ethinyl estradiol + gestodene, 367 levonorgestrel, 267 College health centers, current trends for emergency Yuzpe regimen, 167, 259, 333, 3: contraception pills, 449 Emergency contraceptive pills, Complication, surgical abortion, 49 current trends, 449 Conceptrol, rheological properties, 57 effectiveness, 259 Condom failurers, use of prostate-specific antigen to Ethinyl estradiol + chlormadinone acetate, efficacy and measure semen exposure, 139 tolerability, 305 Contraception, Ethinyl estradiol + desogestrel, counseling in the clinical setting, 115 effect on carbohydrate metabolism, 423 0010-7824/03/$ — see front matter © 2003 Elsevier Inc. All rights reserved 498 Subject Index / Contraception 67 (2003) 497-500 effect on hemostatic variables, 173 ML Cu 375 sl, 273 treatment of hirsutism, 349 Multiload Cu375, 53 Ethinyl estrradiol + dienogest, TCu 380 Nul, 273 effect on sex hormones and serum-binding globulins, TCu 380A, 273 25 Intrauterine system (IUS), levonorgestrel-releasing, 87 effect on thyroid function, adrenal and blood pressure Intravasal RISUG, effect on semen and accessory sex parameters, 361 gland function, 73 Ethinyl estradiol + drospirenone, effect on carbohydrate IUD (intrauterine device) metabolism, 423 IUD insertion, incidence of uterine perforation, 53 Ethinyl estradiol + estradiol valerate dienc gest, IUD insertion post-abortal, safety and acceptability, 229 effect on sex hormones and serum-binding globulins, [UD performance, nulliparious women, 273 25 IUD users, uterine factors and risk of pregnancy, 235 effect on thyroid function, adrenal and blood pressure IUS (intrauterine system) parameters, 36] Ethiny! estradiol + etonogestrel, acceptability of KY Plus, rheological properties, 57 contraceptive vaginal ring, 187 Ethinyl estradiol gestodene, Lactation, effect of norgestrel, 467 clinical experience, 367 Lamicel tent, effect on surgical abortion, 299 effect on bone turnover and bone minerai density, 35° Learning curve, use of mifepristone + misoprostol, 223 effect on hemostatic variables, 173 Levonorgestrel, post-coital treatment (rat), 415 Ethinyl estradiol + levonorgestrel, Levonorgestrel emergency contraception, risk of ectopic effect on bleeding patterns, 9 pregnancy, 267 effect on bone metabolism, 33 Levonorgestrel-releasing IUD, treatment of myoma- effect on hemostatic variables, 173 related menorrhagia, 277 effect on sex hormones and serum-binding globulins, Levonorgestrel-releasing IUS, Zo acceptability, 87 effect on thyroid function, adrenal and blood pressure timing of effects, 473 parameters, 361 Lorazepam, effect during surgical abortion, 219 pharmacological properties, 93 standard vs continuous dosing regimens, 9 Male attitudes, family planning, 133 treatment of hirsutism, 349 Male contraceptive, reversible inhibition of sperm under Ethinyl estradiol + norgestimate, guidance (RISUG), 73 effect on hemostatic variables, 173 Male reproductive system, effect of Mikania glomerata efficacy, safety and cycle control, 431 extract (rat), 327 pharmacologicl properties, 93 Manual vs electric aspiration, surgical abortion, 201, 207 triphasic regimens vs cyclophasic regimens, 431 Mechanism of action, spermicidal agents, 403 Family planning, attitudes and behavior of married men, Yuzpe regimen, 167 133 Medical abortion, Female condom, structural integrity after multiple reuse, mifepristone + misoprostol, 223, 463 65 misoprostol, 457 Female sterilization, postpartum, 385 Medical abortion services, provider survey, 287 FSH (follicle stimulating hormone) Medical or surgical abortion, experience of women, 41 FSH binding inhibitor, antifertility effect (marmoset), 151 Meloxicam, contraceptive effect (rabbit), 485 Menorrhagia, treatment with levonorgestrel-releasing IUD, Gemeprost (Cervagem®), QED effect on surgical abortion, 299 Menstrual problems, effect on Norplant discontinuation, prostaglandin analogue, 299 x13 Gynol II, rheological properties, 57 Methylene blue, effect on sperm, 241 Mifepristone, effect on distribution of progesterone Hemostatic variables, effect of OCs, 173 receptor isoform B, 319 Hirsutism treatment, effect of OCs, 349 Mifepristone + misoprostol, medical abortion, 223, 463 Hormone parameters, effect of OCs, 25 Mikania glomerata extract, effect on male reproductive Hormone profile, effect of tamoxifen (monkey), 409 system (rat), 327 Hypertensive women, effect of OCs, 19 Misoprostol, effect on surgical abortion, 101 Internet website use, emergency contraception, 195 medical abortion, 457 Intrauterine device (IUD), Misoprostol + diclofenac sodium, effect on surgical copper-bearing, 379 abortion, 101 copper-T 380A, 229 Misoprostol sublingual, effect on surgical abortion, 213, inert, 379 295 Subject Index / Contraception 67 (2003) 497-500 ML Cu 375 sl, performance in nulliparous women, 273 Progestogen-only pill, norgestrel, 467 Modern natural family planning methods, interest and use, Prostate-specific antigen level, use to measure semen 253 exposure, 139 Motility of spermatozoa, effect of cupric ions, 16] Provider survey, early abortion services, 287 Multiload Cu375, uterine perforation at insertion, 53 Myoma-related menorrhagia, treatment with Quality of life, following medical or surgical abortion, 41 levonorgestrel-releasing [UD, 277 Myometrium, effect of copper-vasopressin complex, 477 Repeat use, emergency contraception, 421 Natural family planning, interest and use, 253 emergency contraceptive pills, 421 Non-detergent spermicidal agents, mechanism of action, Reuse of female condom, structural integrity, 65 AQ3 Rheological properties, spermicidal gels, 57 Nonoxynol-9 + NuvaRing, interaction with RISUG (reversible inhibition of sperm under guidance), ethinylestradiol and etonogestrel, 27] 73 Norgestimate, pharmacological properties, 93 Norgestrel, Safety, ethinyl estradiol + chlormadinone acetate, 305 effect on lactation, 467 Semen, effect of RISUG, 73 effect on pituitary-ovarian axis, 467 Semen characteristics, effect of tamoxifen (monkey), 409 Norplant discontinuation, effect of menstrual problems, Semen exposure, prostatic-specific antigen level, 139 315 Serum-binding globulins, effect of OCs, 25 Nulliparous women, clinical performance of [UDs, 2 Vis Smoking and OC use, effect on bone mineral density, 439 NuvaRing®, combined contraceptive vaginal ring, 18 7 Sperm motility, NuvaRing + nonoxynol-9, interaction with effect of diltiazem, 241 ethinylestradiol and etonogestrel, 271 effect of methylene blue, 241 Spermatozoa, effect of cupric ions on motility, 16] OC (oral contraceptive) Spermicidal agents, mechanism of action, 403 OC use and smoking, effect on bone mineral density, 439 Spermicidal gels, rheological properties, 57 Oral contraceptive (OC), Sponge vs diaphragm for contraception, 15 ethinyl estradiol + chlormadinone acetate, 305 Structural integrity, reuse of female condoms, 65 ethinyl estradiol + desogestrel, 173, 349, 423 Sublingual misoprostol, effect on cervical priming, 213, ethinyl estradiol + dienogest, 25, 361 295 ethinyl estradiol + drospirenone, 423 Surgical abortion, ethinyl! estradiol - estradiol valerate + dienogest, 25, effect of gemeprost for cervical priming, 299 361 effect of lamicel tent for cervical priming, 299 ethinyl estradiol gestodene, 173, 355, 367 effect of lorazepam, 219 ethinyl estradiol levonorgestrel, 9, effect of misoprostol + diclofenac sodium for cervical 349, 361 priming, 101 ethinyl estradiol norgestimate, 93, effect of sublingual misoprostol for cervical priming, Oral contraceptives, 1s a0 acceptability, 281 manual vs electric aspiration, 201, 207 effect on blood pressure, 19 Surgical abortion complication, plastic cannula fracture, effect on hemostatic variables, | “o1s2 49 effect on sex hormones and serum-binding globulins, Surgical abortion services, provider survey, 287 25 Surgical or medical abortion, experience of women, 41 Over-the-counter status for emergency contraception, ARHP editorial, 341 Tamoxifen, effect on semen characteristics and hormone profile (monkey), 409 Pelvic examination and chaperones, questionnaire survey, TCu 380 Nul, performance in nulliparous women, 273 313 TCu 380A, performance in nulliparous women, 273 Pharmacological properties, norgestimate, 93 Termination of pregnancy, contraceptive practices before Pituitary-ovarian axis activity, effect of norgestrel, 467 and after, 107 Post-abortion IUD insertion, safety and acceptability, 229 Thyroid function, effect of OCs, 361 Post-fertilization events, effect of levonorgestrel (rat), 415 Timing of effects, levonorgestrel-releasing IUS, 473 Postpartum sterilization, demand, 385 Triphasic regimens vs cyclophasic regimens, ethinyl Pregnancy risk in [UD users, effect of uterine factors, 235 estradiol + norgestimate, 431 Pregnancy termination, contraceptive practices before and after, 107 Unintended pregnancy, counseling in the clinical setting, Preserving Core Values in Science Statement, ARHP 115 editorial, 251 Uterine activity, effect of copper, 477 Progesterone receptor isoform B, distribution following Uterine factors, effect on risk of pregnancy in IUD users, mifepristone, 319 125 500 Subject Index / Contraception 67 (2003) 497-500 Uterine perforation, complication of IUD insertion, 53 Website use analysis, emergency contraception, 195 Women’s preferences, vaginal antimicrobial Vaginal antimicrobial contraceptives, women’s contraceptives, 391 preferences, 391 Vaginal ring, NuvaRing®, 187 Yuzpe regimen, Vasectomy, effectiveness, 397 effectiveness, 259 Vitamin D receptor genotype, influence on bone emergency contraception, metabolism, 33 mechanism of action, 167